Lifestyle can shape the composition of beneficial bacteria and other microorganisms within the mouth, according to a new study led by Penn State biologists.
Edgewise shares spike on Phase 2 success for muscular dystrophy drug
Edgewise Therapeutics’ treatment candidate for several forms of muscular dystrophy has hit the primary endpoint in a mid-stage study, setting in motion plans for regulatory